Three USC researchers win $4.3 million in awards from California’s stem cell agency

Three scientists from Keck Medicine of USC have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine (CIRM) for research that includes creating a temporary liver for patients, finding novel ways to treat immune disorders and blood diseases, and developing new animal models for heart failure, diabetes and neurodegenerative diseases. The grants, …


Broad Clinical Fellows take a stem cell-based approach to liver disease and bone loss

This year’s Broad Clinical Research Fellows are developing stem cell-based approaches for patients of all ages—from two-week-old infants with liver disease, to senior citizens with bone loss following joint replacement surgeries. Since 2015, the Broad Clinical Research Fellowships have enabled physician-scientists at USC, UCLA and the University of California, San Francisco, to engage in one …

New study identifies the cellular origin of liver fibrosis

Fibrosis is the process of scar tissue formation. Liver fibrosis can be caused by injury to the liver, chronic viral infection and alcohol abuse. Advanced liver fibrosis can lead to cirrhosis, portal hypertension and liver cancer. Understanding this process is important for prevention and developing treatment. A new study led by Kinji Asahina at the …

Kinji Asahina, PhD

Stay connected.